Skip to main content
Category

Cardiovascular Disease

awardsCardiovascular DiseaseCardiovascular DiseaseCardiovascular Science and Diabetes ProgramHeartImaging and TherapyNews & EventsResearch

Recognition for respected vascular specialist

By | awards, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, Imaging and Therapy, News & Events, Research

Director of the Heart and Vascular Research Institute and Joint Program Head of the Cardiovascular Science and Diabetes Program at the Harry Perkins Medical Research Institute, Professor Shirley Jansen has…

Cardiovascular DiseaseCardiovascular Research & InnovationCardiovascular Science and Diabetes ProgramHeartNews & Events

Researchers develop new AI tool to predict heart attack risk

By | Cardiovascular Disease, Cardiovascular Research & Innovation, Cardiovascular Science and Diabetes Program, Heart, News & Events

Researchers from the Harry Perkins Institute of Medical Research, working with medtech industry partners Artrya Limited, have developed a new, fully-automated AI algorithm that is more effective than current methods…

Cardiovascular DiseaseCardiovascular DiseaseCardiovascular Science and Diabetes ProgramDiabetesFundingNews & EventsResearch

Federal government supports new treatment to clear blocked arteries

By | Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Diabetes, Funding, News & Events, Research

A Western Australian medical research team developing a new treatment for cardiovascular disease has received $2,147,254 in Federal government funding to develop a first-ever drug to clear blocked arteries. The…

Biomedical engineeringCardiovascular DiseaseCardiovascular DiseaseHeartMedia ReleasesNews & EventsT3mPLATE LaboratoryVascular Engineering

3D Printed heart valves to be commercialised

By | Biomedical engineering, Cardiovascular Disease, Cardiovascular Disease, Heart, Media Releases, News & Events, T3mPLATE Laboratory, Vascular Engineering

Cutting-edge biopolymer 3D-printed heart valve technology to be commercialised in Australia to help millions globally suffering from aortic stenosis. CUREator, Australia’s national biotech incubator, funds Western Australian biomedical engineering and…